Published online Aug 28, 2024. doi: 10.4329/wjr.v16.i8.317
Revised: July 15, 2024
Accepted: July 23, 2024
Published online: August 28, 2024
Processing time: 132 Days and 23.4 Hours
Minimally invasive surgery (MIS) and craniotomy (CI) are the current treatments for spontaneous supratentorial cerebral haemorrhage (SSTICH).
To compare the efficacy and safety of MIS and CI for the treatment of SSTICH.
Clinical and imaging data of 557 consecutive patients with SSTICH who underwent MIS or CI between January 2017 and December 2022 were retro
In both conventional statistical and binary logistic regression analyses, the MIS group had a better outcome. The outcome of propensity score matching was unexpected (odds ratio: 0.582; 95%CI: 0.281–1.204; P = 0.144), which indicated that, after excluding the interference of each confounder, different surgical modalities were more effective, and there was no significant difference in their prognosis.
Deciding between MIS and CI should be made based on the individual patient, considering the hematoma size, degree of midline shift, cerebral swelling, and preoperative Glasgow Coma Scale score.
Core Tip: We compared the efficacy and safety of minimally invasive surgery (MIS) and craniotomy (CI) for spontaneous supratentorial cerebral haemorrhage in 557 patients. The prognostic outcome, based on the modified Rankin Scale (mRS) score at 3 months, was evaluated, an mRS score of 0–2 was considered favourable. Before propensity score matching, those who received MIS had a better outcome; however, after accounting for confounding variables, the prognosis was comparable to patients who underwent CI. Deciding between MIS and CI depends on the individual patient, considering the hematoma size, degree of midline shift, cerebral swelling, and preoperative Glasgow Coma Scale score.